<DOC>
	<DOCNO>NCT01181453</DOCNO>
	<brief_summary>This study randomly assign patient diabetic foot ulcer receive standard therapy ( surgical debridement , saline-moistened gauze offload ) alone standard therapy plus Dermagraft ( R ) . Dermagraft device contain live human fibroblast grow absorbable Vicryl mesh . Patients see weekly heal 12-week treatment period complete .</brief_summary>
	<brief_title>Pivotal Trial Dermagraft ( R ) Treat Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Patient 18 year age old . Patient type I II diabetes . Foot ulcer present minimum 2 week current investigator 's care . Foot ulcer plantar surface forefoot heel . Ulcer size &gt; /=1.0 cm2 Day 0 ( day randomization ) . Ulcer extend dermis subcutaneous tissue without exposure muscle , tendon , bone , joint capsule . Ulcer free necrotic debris , exhibit sign clinical infection , appear make healthy vascularized tissue . Patient 's AnkleArm Index Doppler &gt; /=0.7 . Patient adequate circulation foot evidence palpable pulse . Female patient child bear potential must pregnant must use accepted mean birth control . Patient caregiver willing participate clinical study comply followup regimen . Patient his/her legal representative read sign Institutional Review Board ( IRB ) approve Informed Consent form treatment . Patient 's study ulcer present ( open ) least 6 week time Screening visit . There clinical evidence gangrene part affect foot . The study ulcer Charcot deformity . The study ulcer due nondiabetic etiology . The ulcer tunnel sinus tract completely debrided . The ulcer &gt; 20 cm2 ( long dimension great 5 cm ) . The ulcer increase decreased size 50 % screening period . Presence medical condition ( ) Investigator 's opinion make patient inappropriate candidate study . Presence malignant disease remission 5 year . Evidence severe malnutrition , base serum albumin level &lt; 2.0 . Presence patient know alcohol drug abuse . A random blood sugar read &gt; /=450 mg/dL . Presence urine ketone note `` Small , Moderate , Large '' . Presence nonstudy ulcer study foot within 7.0 cm study ulcer Day 0 . Use oral parenteral corticosteroid , immunosuppressive cytotoxic agent , Coumadin heparin study . A history bleed disorder . Presence Acquired Immunodeficiency Syndrome ( AIDS ) Human Immunodeficiency Virus ( HIV ) . Participation another study involve treatment investigational product within previous 30 day . Elective osseous procedure study foot within 30 day prior Screening visit . Previous treatment DermagraftÂ® . Presence study ulcer cellulitis , osteomyelitis clinical evidence infection . Presence condition ( ) seriously compromise patient 's ability complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Diabetic foot ulcer</keyword>
	<keyword>Randomized trial</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Dermagraft</keyword>
	<keyword>Standard care</keyword>
</DOC>